In established breast cancers, ALDH1 expression has been associated with poor clinical outcome (Ginestier et al, 2007) and resistance to chemotherapy (Sladek et al, 2002; Tanei et al, 2009). The gene discussed is ALDH1A1; the disease is breast carcinoma.